Literature DB >> 29355560

miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6.

Yin Yu1, Zhixin Wang2, Daju Sun3, Xueying Zhou4, Xin Wei5, Wei Hou5, Youpeng Ding5, Yanan Ma5, Yi Hou5.   

Abstract

Prostate cancer is one of the most severe malignancies in men, and many genes and non-coding RNAs, included microRNAs (miRs), have been demonstrated to regulate prostate cancer progression. In the present study, we investigated the role of miR-671 in prostate cancer cell proliferation. We found that miR-671 was significantly upregulated in human prostate cancer tissues and cells. miR-671 overexpression promoted prostate cancer cell proliferation, while its downregulation inhibited prostate cancer cell proliferation, as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, colony formation assays, soft agar growth assays, and bromodeoxyuridine (BrdU) incorporation assays. miR-671 directly targets the 3' untranslated region (UTR) of the tumor suppressor SOX6 (encoding SRY (sex determining region Y)-box 6) to inhibit its expression. Double knockdown of miR-671 and SOX6 promoted PC3 cell proliferation, suggesting that miR-671 promotes prostate cancer cell proliferation by inhibiting SOX6.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MiR-671; Prostate cancer; SOX6; Tumor proliferation

Mesh:

Substances:

Year:  2018        PMID: 29355560     DOI: 10.1016/j.ejphar.2018.01.016

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

Review 1.  Sox6, A Potential Target for MicroRNAs in Cardiometabolic Disease.

Authors:  Mohammad Saleem; Sharla Rahman; Fernando Elijovich; Cheryl L Laffer; Lale A Ertuglu; Sepiso K Masenga; Annet Kirabo
Journal:  Curr Hypertens Rep       Date:  2022-02-05       Impact factor: 5.369

2.  MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis.

Authors:  Zhiguo Zhu; Lianmin Luo; Qian Xiang; Jiamin Wang; Yangzhou Liu; Yihan Deng; Zhigang Zhao
Journal:  Cell Death Dis       Date:  2020-11-03       Impact factor: 8.469

3.  [MicroRNA-671-3p suppresses proliferation and invasion of breast cancer cells by targeting DEPTOR].

Authors:  Wei Xia; Degui Gong; Xiaoping Qin; Zhuo Cai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

4.  MicroRNAs and their target mRNAs as potential biomarkers among smokers and non-smokers with lung adenocarcinoma.

Authors:  Sumaria Malik; Rehan Zafar Paracha; Maryam Khalid; Maryum Nisar; Amnah Siddiqa; Zamir Hussain; Raheel Nawaz; Amjad Ali; Jamil Ahmad
Journal:  IET Syst Biol       Date:  2019-04       Impact factor: 1.615

5.  miR-182 modulates cell proliferation and invasion in prostate cancer via targeting ST6GALNAC5.

Authors:  Liang Bai; Li Luo; Weicheng Gao; Chenfeng Bu; Jianfeng Huang
Journal:  Braz J Med Biol Res       Date:  2021-05-24       Impact factor: 2.590

6.  Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells.

Authors:  Wei Jin; Jinsheng Shi; Meiqin Liu
Journal:  Onco Targets Ther       Date:  2019-08-22       Impact factor: 4.147

7.  Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.

Authors:  Bo Chen; Tianshun Gao; Weiwei Yuan; Weihong Zhao; Tza-Huei Wang; Jianqing Wu
Journal:  J Cancer       Date:  2019-10-06       Impact factor: 4.207

8.  SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21CIPI , cyclin D1 and β-catenin.

Authors:  Liyan Lv; Min Zhou; Jian Zhang; Fang Liu; Li Qi; Shuai Zhang; Yi Bi; Yan Yu
Journal:  FEBS Open Bio       Date:  2019-12-12       Impact factor: 2.693

Review 9.  Function of Deptor and its roles in hematological malignancies.

Authors:  Mario Morales-Martinez; Alan Lichtenstein; Mario I Vega
Journal:  Aging (Albany NY)       Date:  2021-01-07       Impact factor: 5.682

10.  MicroRNA-671-3p promotes proliferation and migration of glioma cells via targeting CKAP4.

Authors:  Gui-Feng Lu; Chun-Yue You; Yuan-Shou Chen; Hui Jiang; Xiang Zheng; Wei-Wei Tang; Xian-Yan Wang; Hai-Yan Xu; Fei Geng
Journal:  Onco Targets Ther       Date:  2018-09-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.